These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3131503)

  • 1. Shortened forms of provocative lead chelation.
    Sokas RK; Atleson J; Keogh JP
    J Occup Med; 1988 May; 30(5):420-4. PubMed ID: 3131503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.
    Lee BK; Schwartz BS; Stewart W; Ahn KD
    Occup Environ Med; 1995 Jan; 52(1):13-9. PubMed ID: 7697134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using unstimulated urinary lead excretion to assess the need for chelation in the treatment of lead poisoning.
    Berger OG; Gregg DJ; Succop PA
    J Pediatr; 1990 Jan; 116(1):46-51. PubMed ID: 2104929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of lead nephropathy due to chronic occupational lead exposure].
    Ogata A; Sueta S; Tagawa M
    Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial.
    Lin JL; Ho HH; Yu CC
    Ann Intern Med; 1999 Jan; 130(1):7-13. PubMed ID: 9890856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of lead stores in children: validation of an 8-hour CaNa2EDTA provocative test.
    Markowitz ME; Rosen JF
    J Pediatr; 1984 Mar; 104(3):337-41. PubMed ID: 6423789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of iron deficiency on lead excretion in children with moderate lead intoxication.
    Markowitz ME; Rosen JF; Bijur PE
    J Pediatr; 1990 Mar; 116(3):360-4. PubMed ID: 2106578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of CaNa2EDTA and chelation of lead in renal failure.
    Osterloh J; Becker CE
    Clin Pharmacol Ther; 1986 Dec; 40(6):686-93. PubMed ID: 3096624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental lead exposure and progressive renal insufficiency.
    Lin JL; Tan DT; Hsu KH; Yu CC
    Arch Intern Med; 2001 Jan; 161(2):264-71. PubMed ID: 11176742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance and validity of a shortened lead chelation test.
    Apostoli P; Porru S; Duca P; Ferioli A; Alessio L
    J Occup Med; 1990 Nov; 32(11):1124-9. PubMed ID: 2124260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of lead stores in male veterans.
    Sokas RK; Weller SC; Stolley PD
    J Environ Pathol Toxicol Oncol; 1995; 14(1):53-9. PubMed ID: 7473075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible nephrotoxic reactions to a combined 2,3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels.
    Moel DI; Kumar K
    Pediatrics; 1982 Aug; 70(2):259-62. PubMed ID: 7099793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced vasculotoxic metal excretion in post-myocardial infarction patients following a single edetate disodium-based infusion.
    Arenas IA; Navas-Acien A; Ergui I; Lamas GA
    Environ Res; 2017 Oct; 158():443-449. PubMed ID: 28689036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of lead, zinc, and copper excretion in chronic moonshine drinkers.
    Havelda CJ; Sohi GS; Richardson CE
    South Med J; 1980 Jun; 73(6):710-5. PubMed ID: 6771874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental lead exposure and urate excretion in the general population.
    Lin JL; Tan DT; Ho HH; Yu CC
    Am J Med; 2002 Nov; 113(7):563-8. PubMed ID: 12459402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of a urine protein-to-creatinine ratio assessment in a single voided urine specimen in prediction of 24-hour proteinuria in pregnancy induced hypertension].
    Skweres T; Preis K; Ciepłuch R; Miśkiewicz K
    Ginekol Pol; 2006 Jun; 77(6):415-21. PubMed ID: 16964691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.
    Schwartz BS; McGrail MP; Stewart W; Pluth T
    Occup Environ Med; 1994 Oct; 51(10):669-73. PubMed ID: 8000491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of chelation therapy and factors influencing mortality in lead intoxicated petrol sniffers.
    Burns CB; Currie B
    Aust N Z J Med; 1995 Jun; 25(3):197-203. PubMed ID: 7487685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.